The Maternal, Fetal, and Newborn Health Division has a long tradition and reputation of research excellence in maternal, fetal and newborn health, and is internationally renowned for its bench to bedside translational research.

Overview

Why Our Research is Important

Research Activities

Educational and Training Opportunites

Our Scientists

 

Overview

Our research is focused on (1) studying the mechanisms of normal and abnormal fetal and newborn growth and development; (2) understanding how maternal health and well-being influence fetal and newborn health and development; (3) investigating the long-term effects of abnormal fetal development on childhood health and diseases; and (4) developing non-invasive and safe methods for early detection of abnormal fetal development, and formulating intervention strategies to prevent and treat abnormal fetal development.

 

Why Our Research is Important

There is increasing evidence that children’s health and well-being are largely determined by events during fetal life. By pursuing the four research directions mentioned above, the research conducted by our scientists will lead to development of biomarkers and diagnostic tools for early detection of abnormal fetal development. It will also lead to the development of intervention therapies to prevent and treat abnormal fetal development. In doing so, our research will get to the root of childhood diseases and behavioral disorders, and thus improving the overall quality of life for children

 

Research Activities

For information on current research activities of all CHRI Scientists and Associate Scientists please refer to their individual webpages via the links in the “Our Scientists” table below.

 

Educational and Training Opportunites

Partnerships with Western University’s Departments of Medical Biophysics, Medicine, Obstetrics & Gynaecology, Paediatrics, and Physiology & Pharmacology provide support, funding and research space. This contributes to the recruitment and retention of scientists. 

Consolidating maternal and neonatal clinical services to the new Women and Children’s Tower at London Health Sciences Centre has facilitated clinical sample collection and increased interactions between basic and clinical scientists. The recent appointment of several scientists from the newly established Maternal Health Outcomes Unit is a key component of bringing maternal health into the Children’s Health Research Institute umbrella.

 

Our Scientists

Chair

Dr. Kaiping Yang

Scientists

Dr. Barbra de Vrijer
Dr. Emma Duerden
Dr. Genevieve Eastabrook
Dr. Madhulika Gupta
Dr. Victor Han
Dr. Dan Hardy
Dr. Laudelino Lopes
Dr. Charles McKenzie
Dr. Michelle Mottola
Dr. Jeff Nisker
Dr. Timothy Regnault
Dr. Bryan Richardson
Dr. Samuel Siu

Associate Scientists

Dr. Edith Arany
Dr. Soume Bhattacharya
Dr. Kevin Coughlin
Dr. Orlando daSilva
Dr. Sandrine de Ribaupierre
Dr. Rob Gratton
Dr. Rob Hammond
Dr. David Lee
Dr. Debbie Penava
Dr. Fred Possmayer
Dr. Verinder Sharma
Dr. Keith St. Lawrence